Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gema Pérez-Simó"'
Autor:
Javier Simarro, Gema Pérez-Simó, Nuria Mancheño, Carlos Francisco Muñoz-Núñez, Enrique Cases, Óscar Juan, Sarai Palanca
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1266 (2022)
EGFR tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the treatment of non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. However, targeted therapies impose a strong selective pressure against the coexisting tumor p
Externí odkaz:
https://doaj.org/article/ca4e61345fcb4f6394c6f155c2e1d440
Autor:
Blanca de Unamuno Bustos, Rosa Murria Estal, Gema Pérez Simó, Inmaculada de Juan Jimenez, Begoña Escutia Muñoz, Mercedes Rodríguez Serna, Victor Alegre de Miquel, Margarita Llavador Ros, Rosa Ballester Sánchez, Eduardo Nagore Enguídanos, Sarai Palanca Suela, Rafael Botella Estrada
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract Molecular diagnostics are increasingly performed routinely in the diagnosis and management of patients with melanoma due to the development of novel therapies that target specific genetic mutations. The development of next-generation sequenc
Externí odkaz:
https://doaj.org/article/e39afa7edb1547ada0b0f991d05e9aec
Autor:
Javier, Simarro, Gema, Pérez-Simó, Nuria, Mancheño, Emilio, Ansotegui, Carlos Francisco, Muñoz-Núñez, José, Gómez-Codina, Óscar, Juan, Sarai, Palanca
Publikováno v:
International journal of molecular sciences. 23(15)
In pretreatment tumor samples of
Autor:
Javier Simarro Farinos, Rosa Ballester Sánchez, Margarita Ros, Rosa Murria Estal, Ignacio Torres Navarro, Victor Alegre de Miquel, Sarai Palanca Suela, Rafael Botella Estrada, Gema Pérez Simó, Vicente Sabater Marco, Blanca de Unamuno Bustos
Publikováno v:
MELANOMA RESEARCH
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Several studies have focused on identifying microRNAs involved in the pathogenesis of melanoma. However, its association with clinicopathological features has been scarcely addressed. The aim of this study is to identify microRNAs expression profiles
Autor:
Rosa Murria Estal, Javier Simarro, Gema Pérez Simó, Antonio Sahuquillo Torralba, Rafael Botella Estrada, Estefanía Tarazón, Sarai Palanca Suela, Blanca de Unamuno Bustos
Publikováno v:
Genes; Volume 12; Issue 12; Pages: 1931
Genes
Genes, Vol 12, Iss 1931, p 1931 (2021)
Genes
Genes, Vol 12, Iss 1931, p 1931 (2021)
Recent evidence suggests the existence of a miRNA regulatory network involving human telomerase reverse transcriptase gene (hTERT), with miR-138-5p playing a central role in many types of cancers. However, little is known about the regulation of hTER
Autor:
Ana Beatriz Sánchez Heras, Isabel Chirivella González, Cecilia Egoavil Rojas, Marta Llop García, Zaida García-Casado, Inmaculada de Juan Jiménez, Gema Pérez Simó, Sarai Palanca Suela, María José Juan Fita, José Antonio López Guerrero, Ángel Segura Huerta, Rosa Murria Estal, Ana Santaballa Bertran, Eva Barragán González, Cristina Alenda Gonzalez, Pascual Bolufer Gilabert
Publikováno v:
Familial Cancer. 15:193-200
The study aims to identify the relevance of immunohistochemistry (IHC), copy number aberrations (CNA) and epigenetic disorders in BRCAness breast cancers (BCs). We studied 95 paraffin included BCs, of which 41 carried BRCA1/BRCA2 germline mutations a
Autor:
Vicente Oliver Martínez, Blanca de Unamuno Bustos, Sarai Palanca Suela, Gema Pérez Simó, Margarita Ros, Rosa Murria Estal, Rafael Botella Estrada
Publikováno v:
Journal of the American Academy of Dermatology. 74:570-572
Autor:
Sarai Palanca Suela, Margarita Ros, Rosa Ballester Sánchez, Inmaculada de Juan Jiménez, Blanca de Unamuno Bustos, Gema Pérez Simó, Víctor Alegre de Miquel, Mercedes Rodríguez Serna, Rafael Botella Estrada, Begoña Escutia Muñoz, Eduardo Nagore Enguídanos, Rosa Murria Estal
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Molecular diagnostics are increasingly performed routinely in the diagnosis and management of patients with melanoma due to the development of novel therapies that target specific genetic mutations. The development of next-generation sequencing (NGS)